Wells Fargo Securities' Healthcare Investment Banking Group Names Sumner Anderson as Managing Director

Wells Fargo Securities announced that Sumner E. Anderson will be joining the Healthcare Investment Banking Group as Managing Director.

Anderson will be responsible for generating corporate finance and advisory solutions focusing on clients in the specialty pharmaceutical and biotechnology sectors.

"Sumner's diverse experience across healthcare investment banking and investing makes him positioned to lead our Biopharma effort," said John Hudson, Managing Director and head of Consumer, Healthcare and Gaming Investment Banking.

Prior to joining Wells Fargo, he was the Global Equities Pharmaceutical Analyst at Citadel Investment Group in Chicago where he covered U.S. and European pharmaceutical companies. He began his career in investment banking at Salomon Smith Barney and Thomas Weisel Partners after serving as an officer in the United States Navy.

Wells Fargo & Company is a diversified financial services company with $1.3 trillion in assets, providing banking, insurance, investments, mortgage and consumer finance through more than 10,000 stores and 12,000 ATMs and the internet (wellsfargo.com) across North America and internationally.